These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 21374308)

  • 21. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
    Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [DNA vaccines].
    Prugnaud JL
    Ann Pharm Fr; 2003 Jul; 61(4):219-33. PubMed ID: 12843955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.
    Le Borgne S; Mancini M; Le Grand R; Schleef M; Dormont D; Tiollais P; Rivière Y; Michel ML
    Virology; 1998 Jan; 240(2):304-15. PubMed ID: 9454704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H; Lorenzo G; Rodriguez F; Brun A
    Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.
    Bright RK; Beames B; Shearer MH; Kennedy RC
    Cancer Res; 1996 Mar; 56(5):1126-30. PubMed ID: 8640771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine.
    Xu W; Chu Y; Zhang R; Xu H; Wang Y; Xiong S
    Virology; 2005 Apr; 334(2):255-63. PubMed ID: 15780875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
    Jiang W; Ren L; Jin N
    J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein.
    Pertmer TM; Robinson HL
    Virology; 1999 May; 257(2):406-14. PubMed ID: 10329551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
    Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
    Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with Naked DNA Coexpressing Antigen and Cytokine via IRES.
    Heinrich J; Strack B; Nawrath M; Pavlovic J; Moelling K
    Methods Mol Med; 2000; 29():335-44. PubMed ID: 21374333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA vaccines.
    Ulmer JB; Montgomery DL; Donnelly JJ; Liu MA
    Methods Mol Med; 1996; 4():289-300. PubMed ID: 21359711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA vaccines: a review of developments.
    Webster RG; Robinson HL
    BioDrugs; 1997 Oct; 8(4):273-92. PubMed ID: 18020519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic adjuvants.
    Ertl HC; Pasquini S; He Z; Deng H; Showe L; Giles-Davis W; Wang Y; O I; Marston H; Blaszczyk-Thurin M; Xiang Z
    Methods Mol Med; 2000; 29():251-60. PubMed ID: 21374325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA vaccination : tolerance and autoimmunity.
    Mor G; Eliza M
    Methods Mol Med; 2000; 29():489-97. PubMed ID: 21374343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical safety of DNA vaccines : a method to analyze the distribution of plasmid DNA in animal models.
    Ciccarelli RB; Pachuk CJ; Samuel M; Winter LA; Satishchandran C
    Methods Mol Med; 2000; 29():473-88. PubMed ID: 21374342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro assay of immunostimulatory activities of plasmid vectors.
    Reich CF; Pisetsky DS
    Methods Mol Med; 2000; 29():173-84. PubMed ID: 21374319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.